IL145675A0 - Vascular endothelial cell growth factor variants and uses thereof - Google Patents

Vascular endothelial cell growth factor variants and uses thereof

Info

Publication number
IL145675A0
IL145675A0 IL14567500A IL14567500A IL145675A0 IL 145675 A0 IL145675 A0 IL 145675A0 IL 14567500 A IL14567500 A IL 14567500A IL 14567500 A IL14567500 A IL 14567500A IL 145675 A0 IL145675 A0 IL 145675A0
Authority
IL
Israel
Prior art keywords
growth factor
cell growth
vascular endothelial
endothelial cell
factor variants
Prior art date
Application number
IL14567500A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL145675A0 publication Critical patent/IL145675A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009—Sachets, pouches characterised by the material or function of the envelope
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL14567500A 1999-04-16 2000-04-10 Vascular endothelial cell growth factor variants and uses thereof IL145675A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12978899P 1999-04-16 1999-04-16
US18423500P 2000-02-23 2000-02-23
PCT/US2000/009483 WO2000063380A1 (en) 1999-04-16 2000-04-10 Vascular endothelial cell growth factor variants and uses thereof

Publications (1)

Publication Number Publication Date
IL145675A0 true IL145675A0 (en) 2002-06-30

Family

ID=26827914

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14567500A IL145675A0 (en) 1999-04-16 2000-04-10 Vascular endothelial cell growth factor variants and uses thereof
IL145675A IL145675A (en) 1999-04-16 2001-09-25 Vascular endothelial cell growth factor variants and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL145675A IL145675A (en) 1999-04-16 2001-09-25 Vascular endothelial cell growth factor variants and uses thereof

Country Status (15)

Country Link
US (1) US20060063203A1 (de)
EP (2) EP1655368B1 (de)
JP (1) JP2002541849A (de)
KR (1) KR100634926B1 (de)
CN (1) CN1328376C (de)
AT (2) ATE420177T1 (de)
AU (1) AU771042B2 (de)
CA (1) CA2370246C (de)
DE (2) DE60028565T2 (de)
ES (2) ES2265931T3 (de)
HU (1) HU228898B1 (de)
IL (2) IL145675A0 (de)
MX (1) MXPA01010469A (de)
NZ (1) NZ514488A (de)
WO (1) WO2000063380A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020473A (en) * 1995-08-25 2000-02-01 Genentech, Inc. Nucleic acids encoding variants of vascular endothelial cell growth factor
US7078382B1 (en) 1999-11-02 2006-07-18 Genentech, Inc. Modulation of eNOS activity and therapeutic uses thereof
WO2001032695A2 (en) * 1999-11-02 2001-05-10 Genentech, Inc. MODULATION OF eNOS ACTIVITY AND THERAPEUTIC USES THEREOF
US20050123925A1 (en) 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
AU2003213730A1 (en) * 2002-03-01 2003-09-16 Bracco International B.V. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
WO2003084574A1 (en) 2002-03-01 2003-10-16 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
EP1587944A4 (de) 2002-03-01 2007-03-21 Dyax Corp Kdr und vegf/kdr-bindende peptide und ihre diagnostische und therapeutische veranwendung bei der diagnose und therapie
US7211240B2 (en) * 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
EP2430923A1 (de) 2002-06-05 2012-03-21 Genentech, Inc. Zusammensetzungen und Verfahren zum Leberwachstum und Leberschutz
US7696320B2 (en) 2004-08-24 2010-04-13 Domantis Limited Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor
AU2004219592C1 (en) 2003-03-12 2011-02-24 Genentech, Inc. Use of Bv8 and/or EG-VEGF to promote hematopoiesis
CA2574791A1 (en) 2004-07-20 2006-02-09 Genentech, Inc. Compositions and methods of using angiopoietin-like 4 protein
EP1771474B1 (de) 2004-07-20 2010-01-27 Genentech, Inc. Angiopoietin-like 4 protein hemmer kombinationen und deren verwendung
HUE034109T2 (en) 2005-03-25 2018-01-29 Regeneron Pharma VEGF antagonist formulations
WO2007109183A2 (en) * 2006-03-20 2007-09-27 Novartis Ag Mutations and polymorphisms of fms-related tyrosine kinase 1
SI2944306T1 (sl) 2006-06-16 2021-04-30 Regeneron Pharmaceuticals, Inc. Formulacije antagonista VEGF, primerne za intravitrealno dajanje

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US169292A (en) * 1875-10-26 Improvement in butter-packages
EP0751992B1 (de) * 1994-03-08 2005-11-09 Human Genome Sciences, Inc. Vaskularer endothelialer wachstumsfaktor 2
CN1185159A (zh) * 1995-06-06 1998-06-17 人体基因组科学有限公司 人血管内皮生长因子3
US6020473A (en) * 1995-08-25 2000-02-01 Genentech, Inc. Nucleic acids encoding variants of vascular endothelial cell growth factor
US6750044B1 (en) * 1996-10-17 2004-06-15 Genentech, Inc. Variants of vascular endothelial cell growth factor having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids

Also Published As

Publication number Publication date
US20060063203A1 (en) 2006-03-23
CN1328376C (zh) 2007-07-25
ES2265931T3 (es) 2007-03-01
JP2002541849A (ja) 2002-12-10
HU228898B1 (en) 2013-06-28
ES2320367T3 (es) 2009-05-21
MXPA01010469A (es) 2002-07-30
KR100634926B1 (ko) 2006-10-17
EP1655368A1 (de) 2006-05-10
CA2370246A1 (en) 2000-10-26
HUP0200827A3 (en) 2004-11-29
WO2000063380A1 (en) 2000-10-26
CA2370246C (en) 2017-03-21
DE60041367D1 (de) 2009-02-26
ATE420177T1 (de) 2009-01-15
IL145675A (en) 2010-11-30
DE60028565T2 (de) 2007-06-06
ATE329024T1 (de) 2006-06-15
AU771042B2 (en) 2004-03-11
CN1352684A (zh) 2002-06-05
EP1171594A1 (de) 2002-01-16
EP1171594B1 (de) 2006-06-07
NZ514488A (en) 2004-01-30
HK1093218A1 (en) 2007-02-23
EP1655368B1 (de) 2009-01-07
HUP0200827A2 (en) 2002-06-29
AU4222000A (en) 2000-11-02
KR20020008151A (ko) 2002-01-29
DE60028565D1 (de) 2006-07-20

Similar Documents

Publication Publication Date Title
IL145675A (en) Vascular endothelial cell growth factor variants and uses thereof
EP2016953A3 (de) Vaskuläre endotheliale Zellwachstumsfaktor-Antagonisten und Verwendungen
ATE314395T1 (de) Humanisierte antikörper und verfahren zu ihrer herstellung
BG103232A (en) Heterocyclic esters and amides
DK0939767T3 (da) Procin faktor VIII og hybrider deraf
FR05C0020I1 (de)
DK0851920T3 (da) Varianter af vaskulær endotelcellevækstfaktor, anvendelser af disse samt fremgangsmåder til fremstilling deraf
DK1129186T3 (da) Et faktor VIII-polypeptid med faktor VIII:C-aktivitet
IL146448A0 (en) Dr4 antibodies and uses thereof
MX9604402A (es) Proteina similar a albumina serica humana.
EP0795605A4 (de) Denahrierter low-density lipoprotein (ldl) rezeptor
EP1109454A4 (de) Neisseria meningitidis-polypeptid, nukleinsäuresequenz und verwendungen davon
ATE221204T1 (de) Rezeptorbindungsassay, für den rezeptorbindungsassay geeigneter rekombinanter fusionsrezeptor, vektor zu dessen herstellung sowie reagenziensatz für die durchführung des rezeptorbindungsassays
WO1996018735A3 (en) Tgf-beta superfamily type ii receptor having binding affinity for bone morphogenic protein (bmp)
WO2001021794A3 (en) Smad associating polypeptides
WO2001000824A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS